Legend Biotech (LEGN) market cap
Legend Biotech (LEGN) has a market cap of $3.12B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.01B. That is 32.7% lower than the $5.95B of fiscal 2024. Today's figure is 22.0% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:54 UTC, from Yahoo Finance.
Key facts
- Market cap today
- $3.12B
- Market cap, fiscal 2025
- $4.01B
- Change on fiscal 2024
- −32.7%
- Highest on record
- $10.59Bfiscal 2023
- Lowest on record
- $4.01Bfiscal 2025
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.
Legend Biotech market cap, in more detail
Across the 4 fiscal year-ends on record (2022–2025), the highest was $10.59B in fiscal 2023 and the lowest $4.01B in fiscal 2025.
Market cap at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Legend Biotech market cap, year by year
| Fiscal year | Market cap | Change | Year ended | Share price at year-end | Diluted shares |
|---|---|---|---|---|---|
| Today | $3.12B | — | $16.11 | — | |
| 2025 | $4.01B | 32.7% down | $21.74 | 184.32M | |
| 2024 | $5.95B | 43.8% down | $32.54 | 182.85M | |
| 2023 | $10.59B | 33.4% up | $60.17 | 176.08M | |
| 2022 | $7.94B | — | $49.92 | 159.04M |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.
How to read it
It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.
Legend Biotech, figure by figure
- Legend Biotech revenue
- Legend Biotech earnings
- Legend Biotech earnings per share (EPS)
- Legend Biotech P/E ratio
- Legend Biotech P/S ratio
- Legend Biotech P/B ratio
- Legend Biotech free cash flow
- Legend Biotech operating margin
- Legend Biotech dividend
- Legend Biotech shares outstanding
- Legend Biotech total debt
- Legend Biotech cash on hand
- Legend Biotech total assets
- Legend Biotech return on equity (ROE)
- Legend Biotech return on invested capital (ROIC)
Legend Biotech (LEGN) overview: price, valuation and scorecardAll health care companies by market value
Legend Biotech market cap: questions and answers
What is Legend Biotech's market cap?
Legend Biotech (LEGN) has a market cap of $3.12B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.01B. That is 32.7% lower than the $5.95B of fiscal 2024.
What are the highest and lowest market cap figures on record for Legend Biotech?
Across the 4 fiscal year-ends on record (2022–2025), the highest was $10.59B in fiscal 2023 and the lowest $4.01B in fiscal 2025.
How is Legend Biotech's market cap calculated?
Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Legend Biotech it is on record here for 4 fiscal years, 2022 to 2025.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: market cap
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Legend Biotech (LEGN) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/LEGN/market-cap
Underlying data: Yahoo Finance.